A carregar...
Experience with ospemifene in patients with vulvar and vaginal atrophy and a history of breast cancer: case studies
Women with breast cancer are at a higher risk of developing vulvar and vaginal atrophy (VVA), a major component of the genitourinary syndrome of menopause, due to the combined estrogen-depleting effects of chemotherapy, adjuvant hormone therapy, and menopause. Ospemifene is approved to treat VVA in...
Na minha lista:
| Publicado no: | Drugs Context |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioExcel Publishing Ltd
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7337590/ https://ncbi.nlm.nih.gov/pubmed/32670380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-3-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|